Sangwan Jyoti, Lathwal Sumit, Kumar Satish, Juyal Deepak
Assistant Professor, M.D, DNB, Department of Microbiology & Immunology, Veer Chandra Singh Garhwali Goverment, Medical Sciences & Research Institute , Srinagar Garhwal, PIN: 246174, Uttarakhand, India .
Deputy Assistant Director Health, Indian Armed Forces .
J Clin Diagn Res. 2013 Dec;7(12):2950-1. doi: 10.7860/JCDR/2013/6771.3803. Epub 2013 Dec 15.
Mycobacterium fortuitum, an environmental organism, is capable of producing a variety of clinical infections such as cutaneous infections, abscesses and nosocomial infections. Rarely, it has been a documented as a cause of peritonitis in patients receiving continuous ambulatory peritoneal dialysis (CAPD). Continuous Ambulatory Peritoneal dialysis (CAPD) is one of the treatment options which are used for patients with end-stage renal disease (ESRD). Although peritonitis rates have declined in parallel with advances in peritoneal dialysis (PD) technology, peritonitis remains a leading complication of CAPD and it is the major cause for transfer to other methods of dialysis. We are reporting a case of M. fortuitum peritonitis in a patient who was undergoing CAPD, which was successfully treated. This case emphasizes the importance of mycobacterial cultures in patients with CAPD-associated peritonitis, whose routine cultures may yield no organisms.
偶然分枝杆菌是一种环境微生物,能够引发多种临床感染,如皮肤感染、脓肿和医院感染。在接受持续性非卧床腹膜透析(CAPD)的患者中,它作为腹膜炎病因的情况极为罕见。持续性非卧床腹膜透析(CAPD)是用于终末期肾病(ESRD)患者的治疗选择之一。尽管随着腹膜透析(PD)技术的进步,腹膜炎发生率有所下降,但腹膜炎仍是CAPD的主要并发症,也是转为其他透析方式的主要原因。我们报告了一例正在接受CAPD治疗的患者发生偶然分枝杆菌腹膜炎的病例,该病例已成功治愈。此病例强调了对于CAPD相关性腹膜炎患者进行分枝杆菌培养的重要性,因为其常规培养可能无法检出病原体。